WallStreetZenWallStreetZen

NASDAQ: ATRI
Atrion Corp Earnings & Revenue

OverviewEarnings
DividendOwnership

ATRI past earnings growth

How has ATRI's earnings growth performed historically?
Company
-43.75%
Industry
27.71%
Market
72.61%
ATRI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ATRI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ATRI's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ATRI past revenue growth

How has ATRI's revenue growth performed historically?
Company
-7.73%
Industry
7.53%
Market
17.55%
ATRI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ATRI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ATRI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ATRI earnings and revenue history

Current Revenue
$169.3M
Current Earnings
$19.4M
Current Profit Margin
11.5%
ATRI's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ATRI Return on Equity

Current Company
8.1%
Current Industry
11.1%
Current Market
188%
ATRI's Return on Equity (8.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ATRI announces earnings.

ATRI Return on Assets

Current Company
7.4%
Current Industry
7.2%
ATRI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATRI Return on Capital Employed

Current Company
9.07%
Current Industry
9.7%
ATRI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATRI vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATRI$169.33M$37.62M$19.41M+2.12%-9.83%
ZJYL$19.82M$3.27M$2.88M-2.30%0.00%
BLFS$143.27M-$51.75M-$66.43M+48.65%N/A
EMBC$1.12B$207.60M$55.30M-2.03%-63.46%
PLSE$0.00-$42.37M-$42.21M-100.00%N/A
View Top Medical Stocks

ATRI earnings dates

Next earnings date
May 21, 2024

Atrion Earnings & Revenue FAQ

What were ATRI's earnings last quarter?

On Invalid Date, Atrion (NASDAQ: ATRI) reported Q4 2023 earnings per share (EPS) of $3.64, up 22.55% year over year. Total Atrion earnings for the quarter were $6.42 million. In the same quarter last year, Atrion's earnings per share (EPS) was $4.70.

If you're new to stock investing, here's how to buy Atrion stock.

What was ATRI's earnings growth in the past year?

As of Q2 2024, Atrion's earnings has grown -43.75% year over year. This is 71.45 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 27.71%. Atrion's earnings in the past year totalled $19.41 million.

What is ATRI's earnings date?

Atrion's earnings date is Invalid Date. Add ATRI to your watchlist to be reminded of ATRI's next earnings announcement.

What was ATRI's revenue last quarter?

On Invalid Date, Atrion (NASDAQ: ATRI) reported Q4 2023 revenue of $43.58 million up 1.7% year over year. In the same quarter last year, Atrion's revenue was $42.86 million.

What was ATRI's revenue growth in the past year?

As of Q2 2024, Atrion's revenue has grown -7.73% year over year. This is 15.25 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.53%. Atrion's revenue in the past year totalled $169.33 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.